China authorises CoronaVac COVID-19 vaccine for children above 3 yearsSinovac has finished the Phase I and II clinical research stage, involving several hundred volunteers in this age group, which has proved t...
WHO grants emergency approval to 2nd Chinese COVID vaccineIn a statement Tuesday, the U.N. health agency said data submitted to its experts showed that two doses of the vaccine prevented people fro...
Sinovac COVID-19 vaccine effective but some data lacking - WHO expertsThe assessment came shortly after WHO SAGE experts had voiced "very low confidence" in data provided by Chinese state-owned drugmaker Sinop...
Chinese vaccines' effectiveness low, admits country's top disease control officialThe effectiveness rate of a coronavirus vaccine from Sinovac, a Chinese developer, at preventing symptomatic infections has been found to b...
Sinovac says its vaccine is safe for children as young as 3There were two instances of high fevers in response to the vaccine during trials, one in a 3-year old participant and the other in a six-ye...
China gives approval for broader use of Sinovac vaccineRegulators gave conditional approval for Sinovac Biotech Ltd's shot, CoronaVac, on Friday, clearing the way for general use, The National M...
China approves second domestic Covid-19 vaccineThe vaccine has already been rolled out to key groups at higher risk of exposure to coronavirus but Saturday's approval allows for its use ...
China's COVID-19 vaccine makers apply to join COVAX schemeThe COVAX scheme - led by the World Health Organization and GAVI vaccine alliance - is due to start rolling out vaccines to poor and middle...
Growing uncertainty over efficacy of China made SinovacThe Sinovac allegedly has shown four different efficacy rates during clinical trials ranging from over 91 to 50 per cent. The global scient...
Explainer: What's behind varying efficacy data for Sinovac's coronavirus vaccine?Researchers in Brazil said it was 50.4% effective at preventing symptomatic infections, barely enough for regulatory approval and below the...
China to vaccinate 50 million people for Lunar New Year - SCMPChina has granted emergency-use status to two candidate vaccines from Sinopharm and one from Sinovac Biotech. It has approved a fourth, fro...
Sinovac aims for 600 million dose capacity for COVIDThe company is currently conducting the last stage of clinical trials for its vaccine candidate in Brazil, Turkey and Indonesia and is amon...
Indonesia receives first COVID vaccine from China's SinovacIndonesian President Joko Widodo said in an online briefing that the Southeast Asian country received 1.2 million doses from China's Sinova...
Brazil suspends Sinovac COVID-19 vaccine trial due to adverse eventThe health regulator, Anvisa, said on Monday the event took place on Oct. 29 but did not specify if the incident took place in Brazil or in...
Chinese pharmaceutical firm seeks Bangladesh co-finance for COVID-19 vaccine trialsIn a letter to the Bangladesh government on September 22, Beijing headquartered Sinovac Biotech said the phase 3 trials of the vaccine they...
Chinese firm refuses to honour pact on sharing Covid-19 vaccine tech with BangladeshSinovac Biotech Ltd in a letter on September 24 said the trial would be delayed unless the Bangladesh government provided funds, although t...
'Don't waste a minute': Chinese firm readies mass vaccine productionSinovac Biotech, which is conducting one of the four clinical trials that have been authorised in China, has claimed great progress in its ...